
1. curr treat options gastroenterol. 2002 dec;5(6):451-463.

prevention viral hepatitis.

koff rs(1).

author information: 
(1)division gastroenterology, university massachusetts medical school, 55
lake avenue north, worcester, 01655, usa. koffr@ummhc.org

despite availability vaccines hepatitis b, acute viral
hepatitis due agents continues among commonly reported
notifiable infectious diseases united states. currently available
hepatitis b vaccines highly immunogenic well tolerated, vaccine
coverage needs expanded. use hepatitis vaccine children age 2
years older widespread currently case. hepatitis a
vaccine shown cost effective given children regions
with high attack rates patients chronic hepatitis c. routine newborn 
immunization hepatitis b successful approach disease
control among cost-effective interventions. use hepatitis 
b vaccine sexually active individuals one sex partner
should recommended sexually transmitted disease. availability 
a combined hepatitis b vaccine facilitate vaccine coverage 
individuals risk infections. hepatitis infections which
no vaccine currently available, namely hepatitis c, d, e, reducing
exposure risk modifying lifestyle behaviors control measure
available. early education counseling high-risk behaviors the
acquisition blood-borne hepatitis viruses needs expanded young
children adolescents. eventual eradication hepatitis virus infections 
through universal immunization plausible agents human
beings host effective vaccines developed. hepatitis
e shown zoonosis extensive reservoir pigs, eradication of
this agent may difficult.

doi: 10.1007/s11938-002-0033-y 
pmid: 12408782 

